Venus Medtech (Hangzhou) Inc. (HKG:2500)

Venus Medtech (Hangzhou) Revenue

Venus Medtech (Hangzhou) had revenue of 135.50M CNY in the half year ending June 30, 2026, a decrease of -41.27%. This brings the company's total for the last twelve months to 255.15M, down -40.28% year-over-year. In the year 2025, Venus Medtech (Hangzhou) had annual revenue of 306.79M, down -34.84%. That makes Venus Medtech (Hangzhou) the 29,906th largest company in the world by revenue and 1,785th in Hong Kong.

• Revenue (ttm): 255.15M CNY
• Revenue Growth: -40.28%
• P/S Ratio: 1.53
• Revenue / Employee: 458.07K CNY
• Employees: 557
• Market Cap: 451.03M HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Geography

Chart

• Mainland China 208.46M 68.0%
• Other countries 98.32M 32.0%

Fiscal year ended Dec 31, 2025 See the full Venus Medtech (Hangzhou) breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	306.79M	-164.05M	-34.84%
Dec 31, 2024	470.83M	-20.54M	-4.18%
Dec 31, 2023	491.37M	84.91M	20.89%
Dec 31, 2022	406.46M	-9.40M	-2.26%
Dec 31, 2021	415.86M	139.82M	50.65%

Data Source: S&P Global Market Intelligence Last updated: Sep 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 21, 2026

Data Sources Report a data error